Drug Name and FDA Application Number | Dosage Form/Route | Strength | Marketing Status | Company |
GLIPIZIDE
(ANDA # 074223)
| TABLET; ORAL |
5MG 10MG
|
Prescription
| WATSON LABS |
GLIPIZIDE
(ANDA # 074226)
| TABLET; ORAL |
5MG 10MG
|
Prescription
| MYLAN |
GLIPIZIDE
(ANDA # 074305)
| TABLET; ORAL |
5MG 10MG
|
Prescription
| SANDOZ |
GLIPIZIDE
(ANDA # 074370)
| TABLET; ORAL |
5MG 10MG
|
Prescription
| WATSON LABS |
GLIPIZIDE
(ANDA # 074378)
| TABLET; ORAL |
5MG 10MG
|
Discontinued
| ENDO PHARMS |
GLIPIZIDE
(ANDA # 074387)
| TABLET; ORAL |
5MG 10MG
|
Discontinued
| TEVA |
GLIPIZIDE
(ANDA # 074438)
| TABLET; ORAL |
5MG 10MG
|
Prescription
| ALPHAPHARM |
GLIPIZIDE
(ANDA # 074497)
| TABLET; ORAL |
5MG 10MG
|
Prescription
| IVAX PHARMS |
GLIPIZIDE
(ANDA # 074542)
| TABLET; ORAL |
5MG 10MG
|
Prescription
| SANDOZ |
GLIPIZIDE
(ANDA # 074550)
| TABLET; ORAL |
5MG 10MG
|
Prescription
| KALI LABS |
GLIPIZIDE
(ANDA # 074619)
| TABLET; ORAL |
5MG 10MG
|
Prescription
| PLIVA |
GLIPIZIDE
(ANDA # 075795)
| TABLET; ORAL |
5MG 10MG
|
Prescription
| TORPHARM |
GLIPIZIDE
(ANDA # 076159)
| TABLET, EXTENDED RELEASE; ORAL |
10MG
|
Tentative Approval
| ANDRX PHARMS |
GLIPIZIDE
(ANDA # 076467)
| TABLET, EXTENDED RELEASE; ORAL |
5MG 10MG 2.5MG
|
Prescription
| WATSON LABS |
GLIPIZIDE
(ANDA # 077820)
| TABLET; ORAL |
5MG 10MG
|
Prescription
| CARACO |